Profilo
Cara Cassino worked as an Executive Medical Director at Boehringer Ingelheim Pharmaceuticals, Inc. from 2001 to 2007.
She then worked as the Group VP-Pulmonary Vascular & Rare Diseases at Pfizer Inc. from 2008 to 2013.
In 2014, she was the Senior Vice President at Forest Laboratories, Inc. From 2015 to 2022, she worked as the Chief Medical Officer & EVP-Research & Development at ContraFect Corp.
Prior to her business career, she was a Member of the Pulmonary & Critical Care Medicine Division at New York University School of Medicine.
She earned her doctorate from New York University School of Medicine and her undergraduate degree from NYU College of Dentistry.
Precedenti posizioni note di Cara Cassino
| Società | Posizione | Fine |
|---|---|---|
| CONTRAFECT CORPORATION | Direttore Tecnico/Scientifico/R&S | 14/08/2022 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/09/2015 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2013 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Direttore Tecnico/Scientifico/R&S | 01/01/2007 |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formazione di Cara Cassino
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Forest Laboratories, Inc.
Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
ContraFect Corp.
ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NYU College of Dentistry
NYU College of Dentistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















